Nuchal translucency-based Down syndrome screening: barriers to implementation
Related Experiment Video
Updated: Aug 16, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
1Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland. fmalone@rcsi.ie
Abstract:
Nuchal translucency sonography represents an important step forward in screening for Down syndrome. It is likely that a range of screening programs that rely on nuchal translucency sonography will become popular for general population screening. However, a number of practical implementation issues remain to be resolved before widespread utilization of this technique can be endorsed. This paper addresses some of these issues, including sonographer training, standardized nuchal translucency sonography protocol, ongoing nuchal translucency quality assurance programs, how to interpret Down syndrome risk, availability of first trimester diagnosis, and how to combine screening tests across different gestational ages.
Related Concept Videos
Meiosis I
Karyotyping
